LEG
36
4
KHC
24
13
CHRW
56
-3
NEE
50
-5
URBN
56
14
DD
63
3
LNC
39
3
MA
64
7
MAS
58
2
NOC
43
11
GE
67
2
DNB
82
4
NDAQ
62
2
USB
55
-6
HAS
33
3
MET
72
5
DVN
21
3
SYY
53
4
ACN
52
3
PSX
47
2
LEG
36
4
KHC
24
13
CHRW
56
-3
NEE
50
-5
URBN
56
14
DD
63
3
LNC
39
3
MA
64
7
MAS
58
2
NOC
43
11
GE
67
2
DNB
82
4
NDAQ
62
2
USB
55
-6
HAS
33
3
MET
72
5
DVN
21
3
SYY
53
4
ACN
52
3
PSX
47
2
Financhill
Back

Emergent BioSolutions Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

EBS
Emergent BioSolutions

Last Price:
9.48
Seasonality Move:
13.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Emergent BioSolutions Price Quote

$9.48

Emergent BioSolutions Key Stats

Sell
45
Emergent BioSolutions (EBS) is a Sell
Day range:
$9.37 - $9.67
52-week range:
$1.42 - $15.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.46
P/B ratio:
1.01%
Volume:
794.9K
Avg. volume:
1.5M
1-year change:
353.59%
Market cap:
$513.7M
Revenue:
$1B
EPS:
$-4.1

How Much Does Emergent BioSolutions Make?

Is Emergent BioSolutions Growing As A Company?

  • What Is Emergent BioSolutions's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Emergent BioSolutions's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Emergent BioSolutions Stock Price Performance

What Is Emergent BioSolutions 52-Week High & Low?

Emergent BioSolutions Price To Free Cash Flow

Is It Risky To Buy Emergent BioSolutions?

Is Emergent BioSolutions Cash Flow Positive?

  • What Is EBS Cash Flow From Operations?
    Cash flow from operations (TTM) is $170.7M
  • What Is Emergent BioSolutions’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$185.8M
  • What Is Emergent BioSolutions’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $85.2M

Emergent BioSolutions Return On Invested Capital

  • Is Management Doing A Good Job?
    EBS return on invested capital is -14.79%
  • What Is Emergent BioSolutions Return On Assets?
    ROA measures how assets are converting to revenues and is -12.27%
  • What Is EBS Return On Equity?
    ROE is a measure of profitability and is -35.94%

Emergent BioSolutions Earnings Date & Stock Price

Emergent BioSolutions Competitors

Emergent BioSolutions Dividend Yield

Emergent BioSolutions Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 874.53%
Revenue: 7.5% -1.24%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 12.00
Upside from Last Price: 26.58%

Major Shareholders

  • How many EBS shares are owned by institutional investors?
    42.5M EBS shares are owned by institutional investors
  • How many EBS shares are owned by insiders?
    3.9M EBS shares are owned by insiders